Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent
Rapid decline of pulmonary function in acute respiratory distress syndrome (ARDS) can make ARDS a dangerous and potentially life-threatening condition. Gadolinium-based contrast agents are considered safe alternatives to iodine-based contrast agents, with comparatively fewer adverse effects and a lo...
Main Authors: | Kazuhiko Kato, Shota Fujimoto, Shun Inukai, Hiroki Takatsu, Yu Kono, Kenji Kasai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007119303570 |
Similar Items
-
Acute respiratory distress syndrome after the use of gadolinium contrast agent
by: Bugra Kerget, et al.
Published: (2018-01-01) -
Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report
by: Eduardo Atsushi Osawa, et al.
Published: (2022-11-01) -
Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review
by: Susana Coimbra, et al.
Published: (2024-04-01) -
Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents
by: Nevzat Karabulut
Published: (2015-07-01) -
Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
by: Nat Sakol, et al.
Published: (2020-06-01)